Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT06923917Not Yet Recruiting

European Registry of Acutely Decompensated Pulmonary Arterial Hypertension

Role: collaborator

NCT06114628Phase 2Recruiting

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Role: collaborator

NCT03954574Recruiting

Pulmonary Hemodynamics During Exercise - Research Network

Role: collaborator

NCT05008081Recruiting

The CATALINA Study

Role: collaborator

NCT02757157Not ApplicableTerminated

Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)

Role: lead

NCT04180319Unknown

EARCO REGISTRY. History Of Patients With Alpha-1 Antitrypsin

Role: collaborator

NCT02773836Completed

European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Diseases (EUREST-PLUS)

Role: collaborator

NCT03970564Completed

Neck Ultrasound by Respiratory Physicians in Patients With Lung Cancer

Role: collaborator

NCT02660437Not ApplicableCompleted

pCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD

Role: collaborator

All 9 trials loaded